Free Trial

MetaVia (MTVA) SEC Filings & 10K Form

$1.74 0.00 (0.00%)
As of 02/4/2025 03:59 PM Eastern

Recent MetaVia SEC Filings

DateFilerForm TypeView
01/10/2025
7:30 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:30 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
4:31 PM
Kim Hyung Heon (Reporting)
MetaVia Inc. (Issuer)
MetaVia Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:10 AM
MetaVia Inc. (Filer)
MetaVia Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:35 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
6:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:07 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:20 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:10 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form PRE 14A
07/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form EFFECT
07/24/2024
4:11 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 424B3
07/18/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/16/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
10:11 AM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4/A
06/26/2024
8:15 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:15 PM
DONG-A ST CO., LTD (Filed by)
NeuroBo Pharmaceuticals, Inc. (Subject)
NeuroBo Pharmaceuticals, Inc. (Subject)
MetaVia (Subject)
Form SC 13D/A
06/25/2024
3:16 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 424B5
06/25/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
STRICKLAND D GORDON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Salsbury Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:05 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
7:41 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form DEF 14A
04/30/2024
7:42 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form ARS
04/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form EFFECT
04/17/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
How This Indicator Nailed Nvidia’s Last Two Rallies Perfectly (Ad)

I’m not one to make super bold statements… But today, I’m making an exception. Because I’m 100% convinced this is the best indicator I’ve used for trading Nvidia… Don’t believe me? Just take a look at the last two rallies: This powerful indicator caught both moves almost perfectly.

Don’t miss out—this could be the next big move.
04/01/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
8:20 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
MetaVia (Issuer)
Woodworth Marshall H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
6:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:52 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
MetaVia (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MTVA) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners